Aiming for the outliers: Cancer precision medicine through targeting kinases with extreme expression

2Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

With the increasing availability of highly potent, pharmacologically active, and selective protein kinase inhibitors, identification of individuals who would benefit from targeted kinase inhibitors could facilitate application of precision medicine strategies for cancer therapy. A recent study by Kothari and colleagues reports preclinical studies that highlight the potential of targeting kinases with extreme expression for cancer precision medicine, warranting further clinical investigation of an individual-specific outlier kinase targeting approach. © 2013 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Yegnasubramanian, S., & Maitra, A. (2013). Aiming for the outliers: Cancer precision medicine through targeting kinases with extreme expression. Cancer Discovery, 3(3), 252–254. https://doi.org/10.1158/2159-8290.CD-13-0016

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free